Risk Factors of Cognitive Impairment and Brief Cognitive Tests to Predict Cognitive Performance Determined by a Formal Neuropsychological Evaluation of Primary Health Care Patients

Journal of the American Medical Directors Association

Volumn 17, Issue 4, 2016, Pages 343-347

  Shaik, Muhammad Amin ^a,b   Chan, Qun Lin ^a,b   Xu, Jing ^a,b   Xu, Xin ^a,b   Hui, Richard Jor Yeong ^c   Chong, Steven Shih Tsze ^c   Chen, Christopher Li Hsian ^a,b   Dong, YanHong ^a,b,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^c NATIONAL HEALTHCARE GROUP   (Singapore)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Case finding; Cognitive impairment; Primary care; Risk factors

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BRIEF COGNITIVE TEST; CARDIOVASCULAR RISK; COGNITION; COGNITION ASSESSMENT; COGNITIVE DEFECT; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; NEUROPSYCHOLOGICAL TEST; PRIMARY HEALTH CARE; RISK FACTOR; SINGAPORE; CLINICAL TRIAL; COGNITIVE DYSFUNCTION; MULTICENTER STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COGNITIVE DYSFUNCTION; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PRIMARY HEALTH CARE; RISK FACTORS; SINGAPORE;

EID: 84954348867     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2015.12.007     Document Type: Article

References (31)

1. Wortmann M. Dementia: A global health priority-highlights from an ADI and World Health Organization report. Alzheimers Res Ther 2012, 4:40.
2. Jansen A.P., van Hout H.P., Nijpels G., et al. Yield of a new method to detect cognitive impairment in general practice. Int J Geriatr Psychiatry 2007, 22:590-597.
3. Budd D., Burns L.C., Guo Z., et al. Impact of early intervention and disease modification in patients with predementia Alzheimer's disease: A Markov model simulation. Clinicoecon Outcomes Res 2011, 3:189-195.
4. Borson S., Frank L., Bayley P.J., et al. Improving dementia care: The role of screening and detection of cognitive impairment. Alzheimers Dement 2013, 9:151-159.
5. Lin J.S., O'Connor E., Rossom R.C., et al. Screening for cognitive impairment in older adults: A systematic review for the US Preventive Services Task Force. Ann Intern Med 2013, 159:601-612.
6. Morley J.E., Morris J.C., Berg-Weger M., et al. Brain health: The importance of recognizing cognitive impairment: An IAGG consensus conference. J Am Med Dir Assoc 2015, 16:731-739.
7. Azad N.A., Al Bugami M., Loy-English I. Gender differences in dementia risk factors. Gend Med 2007, 4:120-129.
8. Reisberg B., Gauthier S. Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. Int Psychogeriatr 2008, 20:1-16.
9. Kivipelto M., Ngandu T., Laatikainen T., et al. Risk score for the prediction of dementia risk in 20 years among middle aged people: A longitudinal, population-based study. Lancet Neurol 2006, 5:735-741.
10. Newman A.B., Fitzpatrick A.L., Lopez O., et al. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc 2005, 53:1101-1107.
11. Whitmer R.A., Sidney S., Selby J., et al. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 2005, 64:277-281.
12. Cordell C.B., Borson S., Boustani M., et al. Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting. Alzheimers Dement 2013, 9:141-150.
13. Ismail Z., Rajji T.K., Shulman K.I. Brief cognitive screening instruments: An update. Int J Geriatr Psychiatry 2010, 25:111-120.
14. Galvin J.E., Roe C.M., Powlishta K.K., et al. The AD8: A brief informant interview to detect dementia. Neurology 2005, 65:559-564.
15. Galvin J.E., Roe C.M., Xiong C., et al. Validity and reliability of the AD8 informant interview in dementia. Neurology 2006, 67:1942-1948.
16. Galvin J.E., Fagan A.M., Holtzman D.M., et al. Relationship of dementia screening tests with biomarkers of Alzheimer's disease. Brain 2010, 133:3290-3300.
17. Shaik M.A., Xu X., Chan Q.L., et al. The reliability and validity of the informant AD8 by comparison with a series of cognitive assessment tools in primary healthcare. Int Psychogeriatr 2015, 1-10.
18. Chan Q.L., Xu X., Shaik M.A., et al. Clinical utility of the informant AD8 as a dementia case finding instrument in primary healthcare. J Alzheimers Dis 2015, 49:1-7.
19. Tierney M.C., Naglie G., Upshur R., et al. Factors associated with primary care physicians' recognition of cognitive impairment in their older patients. Alzheimer Dis Assoc Disord 2014, 28:320-325.
20. Rönnlund M., Sundström A., Adolfsson R., et al. Subjective memory impairment in older adults predicts future dementia independent of baseline memory performance: Evidence from the Betula prospective cohort study. Alzheimers Dement 2015, 11:1-8.
21. Narasimhalu K., Ang S., De Silva D.A., et al. Severity of CIND and MCI predict incidence of dementia in an ischemic stroke cohort. Neurology 2009, 73:1866-1872.
22. Narasimhalu K., Ang S., De Silva D.A., et al. The prognostic effects of poststroke cognitive impairment no dementia and domain-specific cognitive impairments in nondisabled ischemic stroke patients. Stroke 2011, 42:883-888.
23. Dong Y., Slavin M.J., Chan B.P., et al. Cognitive screening improves the predictive value of stroke severity scores for functional outcome 3-6 months after mild stroke and transient ischaemic attack: an observational study. BMJ Open 2013, 3:e003105.
24. Ashford J.W., Borson S., O'Hara R., et al. Should older adults be screened for dementia?. Alzheimers Dement 2006, 2:76-85.
25. Yesavage J.A., O'Hara R., Kraemer H., et al. Modeling the prevalence and incidence of Alzheimer's disease and mild cognitive impairment. J Psychiatr Res 2002, 36:281-286.
26. Van Den Berg E., Kloppenborg R.P., Kessels R.P., et al. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition. Biochim Biophys Acta 2009, 1792:470-481.
27. Starr V.L., Convit A. Diabetes, sugar-coated but harmful to the brain. Curr Opin Pharmacol 2007, 7:638-642.
28. Stern Y. Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol 2011, 11:1006-1012.
29. Wong A., Xiong Y.Y., Kwan P.W., et al. The validity, reliability and clinical utility of the Hong Kong Montreal Cognitive Assessment (HK-MoCA) in patients with cerebral small vessel disease. Dement Geriatr Cogn Disord 2009, 28:81-87.
30. Malmstrom T.K., Voss V.B., Cruz-Oliver D.M., et al. The Rapid Cognitive Screen (RCS): A point-of-care screening for dementia and mild cognitive impairment. J Nutr Health Aging 2015, 19:741-744.
31. Tariq S.H., Tumosa N., Chibnall J.T., et al. Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder-a pilot study. Am J Geriatr Psychiatry 2006, 14:900-910.